Schedule 13G ownership disclosure

Context Therapeutics, Inc.

Security class unavailable · CUSIP: 21077P108

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
328,817
Percent of class
2.0600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001999371-24-002145
Form type
SC 13G/A
Filer
Affinity Asset Advisors, LLC
CIK
CIK 1773195
Filed
Feb 13, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub